Trehalose induced antidepressant-like effects and autophagy enhancement in mice
- 1.1k Downloads
The disaccharide trehalose protects cells from hypoxic and anoxic injury and suppresses protein aggregation. In vivo studies with trehalose show cellular and behavioral beneficial effects in animal models of neurodegenerative diseases. Moreover, trehalose was shown to enhance autophagy, a process that had been recently suggested to be involved in the therapeutic action of antidepressant and mood-stabilizing drugs.
The present study was therefore designed to explore antidepressant and mood-stabilizing activity of trehalose in animal models for depression and mania.
Trehalose 1 or 2 % was administered for 3 weeks as a drinking solution to Black Swiss mice (a model of manic-like behaviors) or 2 % to ICR mice and their behavior evaluated in a number of tests related to depression or mania. The effects of trehalose were compared with similar chronic administration of the disaccharide maltose as well as with a vehicle (water) control.
Chronic administration of trehalose resulted in a reduction of frontal cortex p62/beclin-1 ratio suggesting enhancement of autophagy. Trehalose had no mood-stabilizing effects on manic-like behavior in Black Swiss mice but instead augmented amphetamine-induced hyperactivity, an effect similar to antidepressant drugs. In ICR mice, trehalose did not alter spontaneous activity or amphetamine-induced hyperactivity but in two separate experiments had a significant effect to reduce immobility in the forced swim test, a standard screening test for antidepressant-like effects.
The results suggest that trehalose may have antidepressant-like properties. It is hypothesized that these behavioral changes could be related to trehalose effects to enhance autophagy.
KeywordsDepression Bipolar disorder Animal models Cellular plasticity Autophagy
The study was partially supported by a grant from the United States–Israel Binational Science Foundation to Haim Einat and Grant W Anderson (grant # 2011313). The authors would like to thank the Endowment for Medical Research (Huston, TX) for their generous donation of trehalose. We would also like to thank Dr. Shlomit Flaisher-Grinberg, Ms. Sara Schuster, Ms. Keren Raphael, and Mr. Jesse Juetten for their technical assistance.
Conflict of interest
The authors declare no conflict of interest.
- Behan AT, Byrne C, Dunn MJ, Cagney G, Cotter DR (2009) Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in lamp, stxbp1 and basp1 protein expression. Mol Psychiatry 14(6):601–613PubMedCrossRefGoogle Scholar
- Costain WJ, Haqqani AS, Rasquinha I, Giguere MS and Slinn J (2012) Cerebral ischemia induced proteomic alterations: consequences for the synapse and organelles. Advances in the Preclinical Study of Ischemic Stroke. M BalestrinoGoogle Scholar
- Dwyer JM, Lepack AE, Duman RS (2011) Mtor activation is required for the antidepressant effects of mglur2/3 blockade. Int J Neuropsychopharmacol 24:1–6Google Scholar
- Flaisher-Grinberg S, Einat H (2010) Strain specific battery of tests for separate behavioral domains of mania. Front Psychiatry 1(Article 10):1–10Google Scholar
- Garcia LS, Comim CM, Valvassori SS, Reus GZ, Barbosa LM et al (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases bdnf levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 32(1):140–144, Epub 2007PubMedCrossRefGoogle Scholar
- Hiscock KM, Linde JA and Einat H (2007). Black swiss mice as a new animal model for mania: a preliminary study. J Med Biol Sci 1(2)Google Scholar
- Kalinichev M, Dawson LA (2011) Evidence for antimanic efficacy of glycogen synthase kinase-3 (gsk-3) inhibitors in a strain specific model of acute mania. Int J Neuropsychopharmacol 6:1–17Google Scholar
- Rodriguez-Navarro JA, Rodriguez L, Casarejos MJ, Solano RM, Gomez A et al (2010) Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation. Neurobiol 39(3):423–438Google Scholar
- Zschocke J, Zimmermann N, Berning B, Ganal V, Holsboer F, et al (2011) Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons-dissociation from cholesterol homeostasis. Neuropsychopharmacology 2011: 20Google Scholar